Overview

Full Product Details

9798337374789

Table of Contents

Reviews

Author Information

Dr. Dylan Lee holds an MD from a leading medical university, a PhD in Strategic Leadership from a U.S. research university, and an MBA from an accredited U.S. program. He currently serves as Chief Medical Officer at a global biopharmaceutical company, overseeing clinical development and multi-region regulatory strategy. His academic attribution rests on formal appointments in molecular medicine and immunology, graduate-level teaching in research design and clinical methodology, supervision of trainees, and contributions to peer-reviewed scholarship with service as a reviewer/editorial contributor. This scholarly base--methods-driven protocol design, transparent reporting standards, and evidence synthesis--directly underpins his industry leadership. In the healthcare and biopharma sector, he has led end-to-end translation from preclinical rationale to first-in-human and late-phase studies, directed IND/CTA authoring across U.S.-EU-Asia jurisdictions, and built cross-functional governance spanning medical, regulatory, pharmacovigilance, and biostatistics. He has run global, multi-site trials with risk-based monitoring and GxP quality systems, executed portfolio and indication-selection decisions tied to payer-relevant endpoints, and managed cross-border partnerships, diligence, and integration. By coupling clinical training and academic rigor with operational execution, he provides the kind of leadership that moves programs from mechanism to marketed value while meeting scientific, regulatory, and commercial thresholds.

Tab Content 6

Countries Available